{"contacts": [{"terms": [{"accession": "MS:1000586", "name": "contact name", "value": "Przemyslaw Mielczarek"}, {"accession": "MS:1000589", "name": "contact email", "value": "przemyslaw.mielczarek@agh.edu.pl"}, {"accession": "MS:1000590", "name": "contact affiliation", "value": "Department of Analytical Chemistry and Biochemistry, AGH University of Science and Technology, Krakow Poland Maj Institute of Pharmacology, Polish Academy of Sciences, Krakow, Poland"}, {"accession": "MS:1002037", "name": "dataset submitter"}]}, {"terms": [{"accession": "MS:1002332", "name": "lab head"}, {"accession": "MS:1000586", "name": "contact name", "value": "Marzena Mackowiak"}, {"accession": "MS:1000589", "name": "contact email", "value": "mackow@if-pan.krakow.pl"}, {"accession": "MS:1000590", "name": "contact affiliation", "value": "Maj Institute of Pharmacology, Polish Academy of Sciences, Department of Pharmacology, Laboratory of Pharmacology and Brain Biostructure, Smetna Str. 12, 31-343 Krakow, Poland"}]}], "datasetFiles": [{"accession": "MS:1002851", "name": "Other type file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/09/PXD027050/checksum.txt"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/09/PXD027050/sample_MM01_iTraq.d.zip"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/09/PXD027050/sample_MM02_iTraq.d.zip"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/09/PXD027050/sample_MM03_iTraq.d.zip"}, {"accession": "MS:1002846", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/09/PXD027050/sample_MM04_iTraq.d.zip"}, {"accession": "MS:1002848", "name": "Result file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/09/PXD027050/FTtoIxcOE.mzid.gz"}, {"accession": "MS:1002848", "name": "Result file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/09/PXD027050/FTtoIxcOT.mzid.gz"}, {"accession": "MS:1002848", "name": "Result file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/09/PXD027050/FTtoIxcTe.mzid.gz"}, {"accession": "MS:1002848", "name": "Result file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/09/PXD027050/FTtoIxcme.mzid.gz"}, {"accession": "MS:1002850", "name": "Peak list file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/09/PXD027050/Mackowiak_sample_MM01.mgf"}, {"accession": "MS:1002850", "name": "Peak list file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/09/PXD027050/Mackowiak_sample_MM02.mgf"}, {"accession": "MS:1002850", "name": "Peak list file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/09/PXD027050/Mackowiak_sample_MM03.mgf"}, {"accession": "MS:1002850", "name": "Peak list file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/09/PXD027050/Mackowiak_sample_MM04.mgf"}, {"accession": "MS:1002850", "name": "Peak list file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/09/PXD027050/FTtoIxcme.mgf"}, {"accession": "MS:1002850", "name": "Peak list file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/09/PXD027050/FTtoIxcOE.mgf"}, {"accession": "MS:1002850", "name": "Peak list file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/09/PXD027050/FTtoIxcOT.mgf"}, {"accession": "MS:1002850", "name": "Peak list file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/09/PXD027050/FTtoIxcTe.mgf"}], "description": "Background: The present study investigated a role of proteins from BET family (epigenetic readers) in schizophrenia-like abnormalities in MAM-E17 model of schizophrenia. Methods: An inhibitor of BET proteins, JQ1, was given during adolescence in postnatal days (P) 23-P30, and behavioral response (sensorimotor gating, recognition memory) and prefrontal cortex (mPFC) function (long-term potentiation (LTP), molecular and proteomic studies) were performed in adult males and females. Results: Deficits in sensorimotor gating and recognition memory were observed only in MAM-treated males. However, adolescent JQ1 treatment affected control, but MAM-treated groups in both sexes. Electrophysiological study showed an LTP impairment only in male MAM-treated animals, and JQ1 did not have any effect on LTP in the mPFC. In contrast, MAM did not affect immediate early gene expression (markers of neuronal and synaptic activity), but JQ1 altered them in both sexes. Proteomic study revealed alterations in MAM-treated groups only in males, while JQ1 affected both sexes. Conclusions: Prenatal MAM administration induced schizophrenia-like abnormalities only in males. In contrast, adolescent JQ1 treatment affected both sexes and induced behavioral changes in control groups, altered  a markers of neuronal and synaptic activity and proteomic landscape in the mPFC of both groups (VEH- and MAM-treated). Thus, adolescent inhibition of BET family might change neuroplasticity in the mPFC.", "fullDatasetLinks": [{"accession": "MS:1002852", "name": "Dataset FTP location", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2021/09/PXD027050"}, {"accession": "MS:1001930", "name": "PRIDE project URI", "value": "http://www.ebi.ac.uk/pride/archive/projects/PXD027050"}], "identifiers": [{"accession": "MS:1001919", "name": "ProteomeXchange accession number", "value": "PXD027050"}, {"accession": "MS:1001922", "name": "Digital Object Identifier (DOI)", "value": "10.6019/PXD027050"}], "instruments": [{"accession": "MS:1000201", "name": "ultraflex"}], "keywords": [{"accession": "MS:1001925", "name": "submitter keyword", "value": "BET proteins, prefrontal cortex, schizophrenia, mass spectrometry, proteomics, shotgun, MALDI-TOF/TOF"}], "modifications": [{"accession": "MOD:01153", "name": "methylthiolated residue"}, {"accession": "MOD:01549", "name": "iTRAQ8plex-116 reporter+balance reagent acylated residue"}, {"accession": "MOD:00425", "name": "monohydroxylated residue"}], "publications": [{"terms": [{"accession": "MS:1000879", "name": "PubMed identifier", "value": "34445411"}, {"accession": "MS:1002866", "name": "Reference", "value": "Bilecki W, Wawrzczak-Bargie\u0142a A, Majcher-Ma\u015blanka I, Chmelova M, Ma\u0107kowiak M. Inhibition of BET Proteins during Adolescence Affects Prefrontal Cortical Development: Relevance to Schizophrenia. Int J Mol Sci. 2021 22(16)"}]}], "species": [{"terms": [{"accession": "MS:1001469", "name": "taxonomy: scientific name", "value": "Rattus norvegicus (Rat)"}, {"accession": "MS:1001467", "name": "taxonomy: NCBI TaxID", "value": "10116"}]}], "title": "Inhibition of BET proteins during adolescence affects prefrontal cortex development: relevance to schizophrenia"}